In the context of chronic non-cancer pain, a review investigating FSH’s role across various conditions revealed that alterations in FSH levels may modulate pain severity-particularly in female patients-potentially by regulating nervous system sensitivity and pain thresholds [24]. The gene discussed is BRD2; the disease is cancer.